The cannabinoids THC and CBD from medical cannabis can relieve your chronic pain. 
They affect the processes in your body and block the transmission of pain impulses.
Unlike many common medications, medical cannabis is often particularly poor in side effects after the acclimation period. [2,4]
We perform cannabinoid therapy completely digitally. Only for the initial consultation you will meet personally with one of our doctors.
Until the first appointment, the process is free of charge for you - so you can easily find out whether our therapy offer is suitable for you.
Chronic pain is widespread in the German population and can take a wide variety of forms. It can occur in various areas of the body and restrict the life of the person affected accordingly. If pain, for example in the back, occurs for longer than three months, we usually speak of chronic pain.
The causes of chronic pain are as varied as the different forms it takes. One of the most common causes is wear and tear on the musculoskeletal system in adults, such as a herniated disc. Over the years, the body suffers more and more from the strain, which can lead to long-lasting pain sooner or later. Also possible are chronic pain caused by vascular or tumor diseases, as well as neuropathic pain, which can occur, for example, as a result of a stroke.
Chronic pain syndromes also frequently develop after accidents or operations. In addition, migraine disorders can become chronic and be accompanied by regular, severe pain.
It is advisable to treat this chronic pain as soon as possible. This is because over the course of time we form a so-called pain memory. If chronic pain persists for a long time, we eventually perceive it as normal - and even if it improves with painkillers, it can subsequently recur. To avoid this, rapid and decisive treatment makes sense.
Cannabinoid therapy is considered a useful supplement or alternative to classic medication for chronic pain when this has not shown sufficient effect or has been accompanied by severe side effects. Great advantages of medical cannabis are the often low side effects and the usually fast efficacy, which can provide rapid relief in chronic pain. Nevertheless, cannabinoids are not a first-line agent for chronic pain and are explicitly used for the treatment of refractory, persistent pain. 
Our innovative approach at Algea Care: We use the means of digitalization to provide you with the simplest and most personalized therapy possible, tailored precisely to your needs. That's why, apart from the initial consultation, the therapy takes place digitally. This saves you time and gives our doctors the opportunity to focus entirely on you - without a lot of paperwork and effort that keeps them from actually working with our patients. You can start the first steps of your treatment against chronic pain directly from home today.
"Very kind team, very experienced doctors. Simply amazing. State-of-the-art digital healthcare, fully online. This is the future patients are wishing for. "
- Sven S. (34)
"5* aren't enough for to what I feel! From initial contact to follow-up appointments everything works perfectly. Very competent doctors and welcoming staff. I feel like I'm in excellent hands."
- Monica S. (48)
Baron EP, Lucas P, Eades J, Hogue O. Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. J Headache Pain. 2018 May 24;19(1):37. doi: 10.1186/s10194-018-0862-2. PMID: 29797104; PMCID: PMC5968020.
S G, Hb S, K L, R T, Bs R, Ps S, F S, Ab O. Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis. Mult Scler Relat Disord. 2021 Feb;48:102708. doi: 10.1016/j.msard.2020.102708. Epub 2020 Dec 30. PMID: 33387864.
Piper BJ, DeKeuster RM, Beals ML, Cobb CM, Burchman CA, Perkinson L, Lynn ST, Nichols SD, Abess AT. Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. J Psychopharmacol. 2017 May;31(5):569-575. doi: 10.1177/0269881117699616. Epub 2017 Apr 4. PMID: 28372506.
Ran Abuhasira, Lihi Bar-Lev Schleider, Raphael Mechoulam, Victor Novack, Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly, European Journal of Internal Medicine, Volume 49, 2018, Pages 44-50, ISSN 0953-6205.